about
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitCreating a transatlantic research enterprise for preventing Alzheimer's disease2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.Revision of the criteria for Alzheimer’s disease: A symposium.Assessment of cognition in mild cognitive impairment: a comparative studyDeveloping a national strategy to prevent dementia: Leon Thal Symposium 2009.Neuropsychiatric symptoms in Alzheimer's diseaseA roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County StudyA roadmap for the prevention of dementia II: Leon Thal Symposium 2008.Countrywide strategic plans on Alzheimer's disease: developing the framework for the international battle against Alzheimer's disease.Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.Politics of science: Progress toward prevention of the dementia-Alzheimer's syndrome.Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA).Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study.Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.Big data, aging, and dementia: pathways for international harmonization on data sharing.Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.Why a woodpecker?Military risk factors for Alzheimer's dementia and neurodegenerative disease.Diagnosis and assessment of Alzheimer's disease in diverse populations.Zeroing out preventable disability: Daring to dream the impossible dream for dementia care: Recommendations for a national plan to advance dementia care and maximize functioning.Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.A tribute to the Extramural Epidemiology Program, National Institute on Aging.Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database project.Apolipoprotein E genotype and mortality: findings from the Cache County Study.Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.Characteristics of a two-stage screen for incident dementia.The Special Topics Section of Alzheimer's & Dementia.Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples.Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.Global issues in drug development for Alzheimer's disease.Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?Special topic section on health economics and public policy of Alzheimer's disease.Prevent Alzheimer's disease by 2020: a national strategic goal.
P50
Q28709591-8879DC37-B869-4919-A542-52C8008220EBQ28731473-ED8C09D7-A54C-4A8A-9A85-F06E6152071DQ30303063-4C74948E-AF06-4387-8A0C-1059C4317DEFQ30452902-E0EC856A-B608-4D70-BF3B-3FA2E5C27E1DQ33703851-2126CD73-ABF8-4908-AB91-CC621AEDAB64Q34984743-58E95385-4CEB-4DF5-AF0A-643CDB913862Q35823575-6DB7AFCA-F52B-4BA5-8879-3FB24732DEDFQ36893856-9FBF3E51-0654-496C-956B-05C0A60E9F7CQ37199294-E3172C38-474C-4480-B62E-0C127BC21125Q37425789-CC62757A-1BCE-4E27-8A20-1C14BEA3C5B6Q37953077-72272916-3DC5-4584-BD28-47B3CC1E39A7Q38081667-5DC6D57A-61E3-4B0E-87B3-DB516DCF9F1FQ38520798-26AEAFE0-C7A0-4EA5-8C68-947C20F4C4E5Q38657446-F7258808-2B54-439E-9F22-A2ED65008DB3Q39005500-21CF004C-E753-4F20-80C6-96676BF10802Q39623102-C9212EB4-A6FE-4F99-942F-FAC5C5CE402FQ40316491-F4115BE2-BB86-4AF3-B305-EA20EA171257Q42516743-46B2B03C-CAFB-4D5A-BBCC-492937DD8D38Q42623294-4F8C0B90-7E92-448C-9734-65B346B36CB9Q44734509-2813C811-8EB6-490B-9B75-AD49AD8A9971Q44786992-0B6EBA3C-1163-4B59-BA28-7D494EA6A396Q47658804-8796AFBD-AB7D-4413-BA0E-958541EB6374Q48430728-6313C5BD-C488-4DB5-92DD-AD7A38715D58Q48718362-763A98D0-4BFA-4EE6-A8F0-B042CD6F82C6Q49075261-0C072F0A-B470-4AB5-B94E-A85136BB95E8Q49957376-2329F1AD-1448-459C-B474-2762A24DA02CQ51016539-46B26001-9D37-4076-82B0-E70F21A329F7Q51731620-33A7C270-A364-48D8-8221-2FA1E5A98943Q51830566-85968715-52D8-4097-BA13-20BA96EA7551Q51929504-74F0ECDE-8FF5-44B7-84AC-9191FD828005Q51933375-BD438B4A-5F1F-4C2E-9D84-3CE8F5FAD5DDQ51945741-ED583D86-DBD3-40F1-B49C-D94711579186Q52146621-8677F1C0-1B1A-40AD-B0C5-9FF5323660A8Q52589494-9003EA3C-B58B-49EE-BBBB-4FC26A10C3C7Q53058814-B292A497-06A8-436C-982F-2F7D5174EE0FQ53276432-B8BA78EC-A621-4461-8D34-887EC5783E35Q53317530-36FC556F-4D74-4832-AB85-E8C655FB1229Q53375540-FCB77A4D-B853-46B5-9329-F6005FBE18AEQ53386969-5DCD4EA4-11F1-4499-A9DE-B38161B999E0Q53399598-0033C45E-138E-40B1-A4D9-271BF589A1E0
P50
name
Ara S Khachaturian
@en
type
label
Ara S Khachaturian
@en
prefLabel
Ara S Khachaturian
@en